Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axisXuehan Chen, Tie Zhang, Biyin Cao et al.|Acta Pharmacologica Sinica|2019Cited by 41
Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosisShuoyi Jiang, Xinliang Mao, Xiaoge Wang et al.|Cell Death and Disease|2021Cited by 36